Straits Times Index
3,343.35 +11.65 (+0.35%) Nikkei
39,564.45 +222.91 (+0.57%) Hang Seng
17,716.47 -373.46 (-2.06%) FTSE 100
8,179.68 -45.65 (-0.55%) Bitcoin USD
61,459.98 +605.73 (+1.00%) CMC Crypto 200
1,282.23 +16.08 (+1.27%)
TMCI Dec 2024 10.000 call
- GlobeNewswire
Treace to Present at Truist Securities MedTech Conference
Tuesday, June 18, 2024 at 8:00 am Eastern TimePONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside
- GuruFocus.com
Director Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI)
On May 14, 2024, Director Jane Kiernan purchased 19,356 shares of Treace Medical Concepts Inc (NASDAQ:TMCI), as reported in the SEC Filing.
- GuruFocus.com
Director Deepti Jain Acquires 25,000 Shares of Treace Medical Concepts Inc (TMCI)
On May 10, 2024, Deepti Jain, Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 25,000 shares of the company, as reported in a recent SEC Filing.
